Liebross R H, Wetterhahn K E
Department of Chemistry, Dartmouth College, Hanover, NH 03755.
Carcinogenesis. 1992 Nov;13(11):2113-20. doi: 10.1093/carcin/13.11.2113.
In order to understand the possible role of reactive intermediates in the formation of tissue-specific DNA damage by chromium(VI), electron paramagnetic resonance spectroscopy was used to study the in vivo formation of chromium(V) in the liver and red blood cells of 14 day chick embryos following treatment with chromium(VI). In vivo administration of sodium dichromate onto the inner shell membrane of 14 day chick embryos resulted in the formation of a persistent chromium(V) species in liver cells (g = 1.987). The intensity of the chromium(V) signal in liver cells plateaued at 70 min and persisted for 240 min after treatment with chromium(VI). The dependence of chromium(V) formation on the dose of sodium dichromate administered to the embryo was clearly different in liver versus red blood cells. Chromium(V) was detected in red blood cells only at high doses of sodium dichromate (0.50-0.60 mmol/kg), whereas chromium(V) was undetectable in red blood cells at lower doses of sodium dichromate (0.10-0.30 mmol/kg) which produced clear evidence for chromium(V) in liver. Uptake studies showed that total chromium levels in red blood cells were 10-fold greater than in liver cells, and that up to 10% of the total chromium existed as chromium(V) in liver and red blood cells in vivo. Depletion of glutathione by pretreatment of embryos with L-buthionine-S,R-sulfoximine (BSO) for 24 h prior to treatment with a high dose of sodium dichromate (0.60 mmol/kg) caused both a decrease in the levels of chromium(V) species produced and a decrease of chromium uptake into red blood cells 50 min after treatment. At this high dose of chromium(VI), BSO pre-treatment had no effect on the level of the chromium(V) or on chromium uptake into liver cells after a 70 min incubation period. Thus, the concentration of chromium(V) inside the cell correlated with the levels of chromium taken up into the cell. Chromium(V) may be the form of chromium which is responsible for induction of DNA damage following in vivo administration of sodium dichromate.
为了了解反应性中间体在六价铬诱导组织特异性DNA损伤过程中可能发挥的作用,采用电子顺磁共振波谱法研究了14日龄鸡胚经六价铬处理后肝脏和红细胞中五价铬的体内形成情况。将重铬酸钠体内注射到14日龄鸡胚的内壳膜上,导致肝细胞中形成一种持久的五价铬物种(g = 1.987)。六价铬处理后,肝细胞中五价铬信号强度在70分钟时达到稳定,并持续240分钟。肝脏和红细胞中五价铬的形成对注射到胚胎体内的重铬酸钠剂量的依赖性明显不同。仅在高剂量重铬酸钠(0.50 - 0.60 mmol/kg)时红细胞中可检测到五价铬,而在较低剂量重铬酸钠(0.10 - 0.30 mmol/kg)时红细胞中未检测到五价铬,此时肝脏中已出现明显的五价铬证据。摄取研究表明,红细胞中的总铬水平比肝细胞高10倍,并且在体内肝脏和红细胞中高达10%的总铬以五价铬形式存在。在高剂量重铬酸钠(0.60 mmol/kg)处理前24小时,用L-丁硫氨酸-S,R-亚砜亚胺(BSO)预处理胚胎以消耗谷胱甘肽,导致处理后50分钟产生的五价铬物种水平降低以及红细胞对铬的摄取减少。在这个高剂量六价铬处理下,BSO预处理在70分钟孵育期后对五价铬水平或肝细胞对铬的摄取没有影响。因此,细胞内五价铬的浓度与细胞摄取的铬水平相关。五价铬可能是重铬酸钠体内给药后诱导DNA损伤的铬的存在形式。